Heat vs. Fatigue: Hyperthermia as a Possible Treatment Option for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26115339 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Barbara Hochecker und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Albstadt-Sigmaringen University of Applied Sciences, Anton-Günther-Strasse 51, 72488 Sigmaringen, Germany. Hauptthemen laut MEDLINE: Fatigue Syndrome, Chronic, Hyperthermia, Induced, Fatigue. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Professor Manfred von Ardenne Forschungsförderungsgesellschaft e.V..
Abstract (Originalsprache)
The aetiology and pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) have not yet been clarified. Its exact diagnosis is also difficult because it has no biomarkers. This lack of knowledge leads to difficulties in treating the disease. In our work, we are attempting to counteract this problem by analysing the central cellular mechanisms in ME/CFS patients and comparing them with those of healthy individuals. This pilot study provides a small glimpse into the journey of nine people with ME/CFS—more specifically, how their peripheral blood mononuclear cells (PBMCs) responded immediately after a session of whole-body hyperthermia (WBH). The clinical effect of WBH has already been investigated in other studies on the treatment of ME/CFS, and these studies have provided valuable insights into its potential benefits. The present study is concerned with the investigation of cellular parameters, namely autophagy, mitochondrial function and mRNA expression, before and after WBH. The results suggest that ME/CFS patients may have higher autophagy-related protein light chain 3 (LC3)-II levels and increased mitochondrial function compared with healthy individuals. A whole-body hyperthermia session could lead to a reduction in LC3-II levels, resulting in a reversion to the levels observed in healthy donors. In the case of mitochondrial parameters, hyperthermia could lead to an increase in the measured parameters. This pilot study is a continuation of a previously published study in which only the isolated cells of ME/CFS patients and a healthy control group were treated with hyperthermia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Life Sciences, Albstadt-Sigmaringen University of Applied Sciences, Anton-Günther-Strasse 51, 72488 Sigmaringen, Germany.
- Von Ardenne Institute of Applied Medical Research GmbH, 01324 Dresden, Germany.
ORCID-Profile: Barbara Hochecker, Melanie Scherer
Förderung
- Professor Manfred von Ardenne Forschungsförderungsgesellschaft e.V.
Zitieren
APA
Hochecker, B., Matt, K., Scherer, M., Meßmer, A., von Ardenne, A., & Bergemann, J. (2025). Heat vs. Fatigue: Hyperthermia as a Possible Treatment Option for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115339
Vancouver
Hochecker B, Matt K, Scherer M, Meßmer A, von Ardenne A, Bergemann J. Heat vs. Fatigue: Hyperthermia as a Possible Treatment Option for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115339
BibTeX
@article{Hochecker2025,
author = {Hochecker, Barbara and Matt, Katja and Scherer, Melanie and Meßmer, Alica and von Ardenne, Alexander and Bergemann, Jörg},
title = {Heat vs. Fatigue: Hyperthermia as a Possible Treatment Option for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26115339}
}
EUVIMED